AzTrials
AzTrials

Cardiac Arrest, Out-Of-HospitalACEP-V2NCT06603649

Evaluation of Updated Procedure for Management of Refractory Out-of-hospital Cardiac Arrests

An observational study of Cardiac Arrest, Out-Of-Hospital, run by Central Hospital, Nancy, France at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

ECPR is a technique that has been rapidly developed in many cardiac arrest specialized centers In 2013, a specific management protocol was developed for patients in refractory out-of-hospital cardiac arrest around Nancy, France. To select patients with the best prognosis, the inclusion criteria defined were strict. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Cardiac Arrest, Out-Of-Hospital
What is being tested?
ECPR for out-of-hospital cardiac arrest
How many people
150 participants
Where
1 siteFrance
Study dates
1 Oct 2024to 31 Dec 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients presenting with refractory out-of-hospital cardiac arrest and enrolled in the ECPR program in Nancy, France. Inclusion criteria for the ECPR program are the following: * Age: 18-65 years * No major comorbidity * Witnessed non traumatic cardiac arrest * Low-flow to ECPR estimated of less than 60 minutes

Who may be able to join

  • Out-of-hospital cardiac arrest
  • enrolled in the ECPR program
  • 18 years old or more
  • Low-flow estimated <60minutes

Who cannot join

  • traumatic cardiac arrest
  • major comorbidities

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • CHRU

    Nancy

    Deborah Jaeger, MD, PhD, d.jaeger@chru-nancy.fr

Other trials in France

About this study

Official title: Evaluation of the Updated Procedure for the Management of Refractory Out-of-hospital Cardiac Arrests with SAMU 54 : the Revised ACEP Protocol in 02/2024

ECPR is a technique that has been rapidly developed in many cardiac arrest specialized centers In 2013, a specific management protocol was developed for patients in refractory out-of-hospital cardiac arrest around Nancy, France. To select patients with the best prognosis, the inclusion criteria defined were strict. This led to an over-selection of patients and a significant reduction in the number of eligible patients. A balance needed to be struck between over-selecting patients and maintaining the expertise of medical and paramedical teams in the field. In addition, it has also been shown that ECPR also increases the number of organs and transplants.

In February 2024, the criteria for inclusion in the protocol were redefined to include any witnessed non-traumatic cardiac arrest, whatever the initial rhythm. This simplification should enable more patients to be included in the procedure.

The aim of the study is to assess the patient's outcome

Being tested
ECPR for out-of-hospital cardiac arrest
Medical subject headings
Out-of-Hospital Cardiac Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ECPR for out-of-hospital cardiac arrestOther

    Patient with out-of-hospital cardiac arrest enrolled in the ECPR protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survival

    Survival rate of patients enrolled in the protocol

    Measured: 90 days after cardiac arrest

Secondary outcomes (2)
  1. Delays

    Delay between cardiac arrest and ECPR implementation

    Measured: From event to implementation of ECMO, in minutes, Up to 180 minutes

  2. Neurological outcome

    Evaluation of neurological outcome of survivors after cardiac arrest using the Rankin score

    Measured: 30 days and 90 days after cardiac arrest

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start1 Oct 2024 (estimated)
  3. Primary completion1 Sep 2030 (estimated)
  4. Study completion31 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06603649
Sponsor's protocol ID
2024PI049
Acronym
ACEP-V2
Status last verified
Aug 2024
First submitted
28 Aug 2024
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Arrest, Out-Of-Hospital, run by Central Hospital, Nancy, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survival (time frame: 90 days after cardiac arrest). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in